The effects of intravenous diltiazem for aged patients with hypertension crisis
Lin Hon
Abstract
Lin Hon
Abstract
Objective To evaluate the effects of intravenous diltiazem for aged patients with hypertension crisis. Methods Intravenous diltiazem was given to group A(n=30, SBP 192.4±17.2mmHg and DBP 110.6±8.8 mmHg) 10-20 mg, and intravenous nitroglycerin was given to group B(n=31, SBP 189.7±16.9 mmHg and DBP 112.8± 7.4 mmHg) 10 mg within 2 hours. The blood pressure (BP) was observed after 5 min, doses recorded and regulated according to BP, ECG, HR, SBP, DBP, HR×SBP and tolerance dosage. Results After treatment with diltiazem and nitroglycerin the BP of all patients decreased significantly(P0.01). More adverse events like headache(8 patients), dizziness, swelling, palpitation(6 patients) developed and 3 patients could not tolerate in group B. ST-T, in ECG improved in 2 groups but there was no statistical significance. None suffered from A-VB, severe low BP and heart failure. Conclusions The intravenous diltiazem is more effective and safer to treat aged patients with hypertension crisis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the effects of intravenous diltiazem for aged patients with hypertension crisis. Methods Intravenous diltiazem was given to group A(n=30, SBP 192.4±17.2mmHg and DBP 110.6±8.8 mmHg) 10-20 mg, and intravenous nitroglycerin was given to group B(n=31, SBP 189.7±16.9 mmHg and DBP 112.8± 7.4 mmHg) 10 mg within 2 hours. The blood pressure (BP) was observed after 5 min, doses recorded and regulated according to BP, ECG, HR, SBP, DBP, HR×SBP and tolerance dosage. Results After treatment with diltiazem and nitroglycerin the BP of all patients decreased significantly(P0.01). More adverse events like headache(8 patients), dizziness, swelling, palpitation(6 patients) developed and 3 patients could not tolerate in group B. ST-T, in ECG improved in 2 groups but there was no statistical significance. None suffered from A-VB, severe low BP and heart failure. Conclusions The intravenous diltiazem is more effective and safer to treat aged patients with hypertension crisis.
Key concepts: Diltiazem, Medicine, Blood pressure, Adverse effect, Anesthesia, Cardiology, Internal medicine, Calcium